A new method for creating a Potts shunt to improve blood flow in patients.
Official title: SBIR TOPIC 107, PHASE II, TRANSCATHETER POTTS SHUNT
Funded at Transmural Systems, LLC · NIH-10975068 · Data updated 2026-11-12
This study is looking at a new, less invasive heart procedure that could help improve blood flow for patients with specific heart conditions, making recovery easier and faster than traditional surgery.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Transmural Systems, LLC NIH-funded |
| Lab location | 1 site (Andover, United States) |
| Project start | September 21, 2023 |
| Project end | September 20, 2026 |
| Funding year | 2023 |
| Award (this year) | $2,999,357 |
| NIH project number | 75N92023C00028-0-9999-1 |
| Project ID | NIH-10975068 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research would include patients with congenital heart defects or other conditions requiring improved blood flow.
✕Less likely to help
Patients with severe heart failure or those who are not candidates for any form of surgical intervention may not benefit from this research.
What this research studies
This research focuses on developing a transcatheter Potts shunt, a minimally invasive procedure designed to improve blood flow in patients with certain heart conditions. The approach involves using advanced catheter techniques to create a connection between the pulmonary artery and the aorta, which may help alleviate symptoms and improve overall heart function. Patients may benefit from a less invasive option compared to traditional surgical methods, potentially leading to quicker recovery times and reduced hospital stays.
Why it matters
Potential benefit: If successful, this research could provide a safer and more effective treatment option for patients with specific heart conditions.
How similar studies have gone: While the concept of transcatheter procedures has shown promise in other areas of cardiology, this specific approach to the Potts shunt is relatively novel and has not been widely tested.
Where this research is happening
-
Transmural Systems, LLC
Andover, United States Active
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.